The Brighterside of News on MSN
New drug combination boosts life expectancy from grade 3 brain tumors by 45% or more
A Phase 3 STELLAR trial across 74 North American and European sites shows a drug combo helps adults with recurrent grade 3 astrocytoma live longer and healthier.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback